Marksans Pharma Ltd share price logo

Marksans Pharma Share Price

NSE: MARKSANS

BSE: 524404

Small Cap

Healthcare Sector

₹178.37

-0.87

(-0.49%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Marksans Pharma Stock Performance

as on September 18, 2025 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹176.71
    ₹181.6
    downward going graph

    0.93%

    Downside

    1.81%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹165.52
    ₹358.7
    downward going graph

    7.20%

    Downside

    101.10%

    Upside

    downward going graph

Marksans Pharma share price movements today

Previous Close
₹179.24
Open
₹180.63
Volume
8.77L
Upper Circuit
₹215.08
Lower Circuit
₹143.39
Day's Low - High
₹176.71 - ₹181.6
52 Week Low - High
₹165.52 - ₹358.7

Marksans Pharma Historical Returns

1 Month Return
-2.72 %
3 Month Return
-28.35 %
1 Year Return
-36.26 %
3 Year Return
+ 250.76 %
5 Year Return
+ 250.42 %

Marksans Pharma Fundamentals

as on September 18, 2025 at 4:01 pm IST

Market Cap

₹8,122.51 Cr

Return on Equity (ROE)

14.45

PE Ratio (TTM)

23.19

Return on capital employed (ROCE)

18.55

Industry PE ratio

42.21

Beta (LTM)

1.45

P/B Ratio

7.28

Dividend Yield

0.36

PEG Ratio

64.41

Quarterly Earnings Growth YOY

-34.66

EPS (TTM)

8.44

Sector

Pharmaceuticals

Book Value

54.44

Technical Analysis

Bearish

View Technical Analysis

Marksans Pharma Stock Valuation

as on September 18, 2025 at 4:01 pm IST

Marksans Pharma in the last 5 years

  • Overview

  • Trends

Lowest (4.67x)

April 1, 2020

Today (23.19x)

September 17, 2025

Industry (42.21x)

September 17, 2025

Highest (46.60x)

January 24, 2018

LowHigh

Today’s Price to Earnings Ratio: 23.19x

Marksans Pharma Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Marksans Pharma with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Marksans Pharma Ltd image
Marksans Pharma Ltd
BUY8,122.5150.08%0.563822,622
Medico Remedies Ltd image
Medico Remedies Ltd
NA323.0612.17%0.0010150
Alivus Life Sciences Ltd image
Alivus Life Sciences Ltd
BUY11,519.785.09%0.004852,386
Shukra Pharmaceuticals Ltd image
Shukra Pharmaceuticals Ltd
NA1,315.392290.77%0.00932
NGL Fine Chem Ltd image
NGL Fine Chem Ltd
NA836.28-5.52%0.6121368
See all

Analyst Recommendation on Marksans Pharma Stock

Based on 3 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for Marksans Pharma. Average target price of ₹231.67

Source: S&P Global Market Intelligence

Marksans Pharma Share Price Target

Get share price movements and forecasts by analysts on Marksans Pharma.

What analysts predicted

29.25%UPSIDE

Target Price

₹231.67

Current Price

₹178.37

Analyzed by

3 Analysts

High

₹265

Target

₹231.67

Low

₹210

Marksans Pharma target price ₹231.67, a slight upside of 29.25% compared to current price of ₹178.37. According to 3 analysts rating.

Source: S&P Global Market Intelligence

Marksans Pharma Stock's Interest Amongst Investors

Investment in Marksans Pharma Ltd Shares on INDmoney has grown by 23.52% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:23.52% versus previous 30 day period

Search interest for Marksans Pharma Ltd Stock has increased by 5% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:5% versus previous 30 day period

Marksans Pharma Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sales
452.57
479.83
485.98
500.03
531.24
586.13
560.01
590.62
641.92
681.85
708.46
619.99
Other Income
14.15
17.65
11.01
10.1
19
4.8
16.53
14.95
11.06
27.85
15.34
5.64
Total Income
466.72
497.48
496.99
510.13
550.23
590.93
576.54
605.57
652.98
709.7
723.8
625.63
Expenses
372.3
403.19
376.43
398.07
417.29
453.11
450.37
462.18
506.24
543.08
581.52
519.87
Operating Profit
80.27
76.64
109.55
101.96
113.95
133.02
109.64
128.44
135.68
138.77
126.94
100.12
Operating Profit Margin %
17.74%
15.97%
22.54%
20.39%
21.45%
22.69%
19.58%
21.75%
21.14%
20.35%
17.92%
16.15%
Profit Before Interest, Tax and Depreciation
94.42
94.3
120.56
112.06
132.95
137.82
126.17
143.39
146.74
166.61
142.27
105.76
Interest
2.54
2.35
2.44
1.58
1.63
3.16
4.84
2.92
2.63
2.67
3.44
6.07
Depreciation
14.05
12.74
13.94
13.66
17.55
22
21.06
20.44
19.51
20.69
22.74
23.1
Profit Before Tax
77.83
79.21
104.18
96.82
113.77
112.66
100.27
120.03
124.6
143.25
116.09
76.59
Tax Paid
17.71
16.9
21.47
26.38
29.91
29.7
22.63
30.95
26.84
38.19
25.37
18.4
Profit After Tax
60.12
62.31
82.71
70.44
83.85
82.97
77.64
89.07
97.76
105.07
90.73
58.2
Total Net profit including share of profit / Loss from associate company
60.12
62.31
82.71
70.44
83.85
82.97
77.64
89.07
97.76
105.07
90.73
58.2
EPS
1.52
1.56
1.97
1.52
1.84
1.84
1.73
1.96
2.13
2.31
2
1.29
Actual EPS
1.52
1.56
1.97
1.52
1.84
1.84
1.73
1.96
2.13
2.31
2
1.29
Adjusted EPS
1.52
1.56
1.97
1.52
1.84
1.84
1.73
1.96
2.13
2.31
2
1.29
Diluted EPS
1.52
1.56
1.97
1.52
1.84
1.84
1.73
1.96
2.13
2.31
2
1.29

Marksans Pharma Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
767.16
912.69
1,000.07
1,134.21
1,376.18
1,490.84
1,852.14
2,177.41
2,622.85
Other Income
7.02
8.47
4.62
0.33
6.69
41.85
59.31
50.42
66.33
Total Income
774.18
921.17
1,004.69
1,134.54
1,382.88
1,532.69
1,911.45
2,227.83
2,689.17
Expenses
722.42
834.31
867.92
941.96
1,036.58
1,231.96
1,512.82
1,718.83
2,090.16
Operating Profit
44.74
78.38
132.15
192.25
339.6
258.88
339.32
458.58
532.69
Operating Profit Margin %
5.83%
8.59%
13.21%
16.95%
24.68%
17.36%
18.32%
21.06%
20.31%
Profit Before Interest, Tax and Depreciation
51.77
86.86
136.77
192.58
346.3
300.73
398.63
509
599.01
Interest
6.78
10.22
9.66
8.75
7.99
8.45
9.13
11.2
11.66
Depreciation
30.09
26.84
22.8
26.66
36.15
44.78
51.85
74.27
83.39
Profit Before Tax
14.9
49.8
104.31
157.17
302.16
247.5
337.65
423.53
503.96
Tax Paid
3.56
14
23.88
36.42
63.62
60.7
72.33
108.63
121.35
Profit After Tax
11.34
35.8
80.44
120.75
238.54
186.81
265.32
314.9
382.62
Total Net profit including share of profit / Loss from associate company
11.34
35.8
80.44
120.75
238.54
186.81
265.32
314.9
382.62
EPS
0.22
0.8
1.87
2.86
5.76
4.51
6.41
6.92
8.4
Actual EPS
0.22
0.8
1.87
2.86
5.76
4.51
6.41
6.92
8.4
Adjusted EPS
0.22
0.8
1.87
2.86
5.76
4.51
6.41
6.92
8.4
Diluted EPS
0.22
0.8
1.87
2.86
5.76
4.51
6.41
6.92
8.4

Marksans Pharma Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
30.8
14.06
50.09
27.4
233.33
178.59
99.26
237.41
230.41
206.66
Cash Flow from Investing Activities
-123.01
-20.72
-38.81
-13.48
-59.59
-44.85
-84.4
-259.2
-140.84
-49
Cash Flow from Financing Activities
-57.75
-3.48
3.39
-20.78
-113.56
-15.28
79.52
197.83
-68.73
-65.16
Net Cash Flow
-149.96
-10.14
14.67
-6.86
60.19
118.46
94.38
176.03
20.84
92.51

Marksans Pharma Stock Shareholding Pattern

Numbers in percentages

Dec 2022
Jan 2023
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Promoters
49%
43.8%
43.85%
43.85%
43.85%
43.85%
43.85%
43.87%
43.87%
43.87%
43.87%
43.87%
DII
0.96%
0.87%
1.46%
3.65%
3.15%
3.82%
5.17%
3.75%
4.1%
4.3%
4.56%
5.5%
FII
0%
10.88%
10.88%
10.88%
10.88%
10.88%
15.57%
18.6%
21.31%
21.96%
22.2%
19.88%
Public
45.8%
40.5%
39.58%
37.59%
37.06%
35.83%
35.4%
33.78%
30.71%
29.87%
29.37%
30.75%
Total Outstanding Shares
40,30,34,114
45,31,63,746
45,31,63,746
45,31,63,746
45,31,63,746
45,31,63,746
45,31,63,746
45,31,63,746
45,31,63,746
45,31,63,746
45,31,63,746
45,31,63,746
Total Shareholders
2,13,123
2,09,299
1,98,382
1,88,447
2,07,937
2,37,377
2,54,699
2,35,500
2,48,845
2,59,813
2,57,273
2,56,221

Mutual Funds that own Marksans Pharma Stock

Check out the Mutual Funds with significant holdings in Marksans Pharma.

Marksans Pharma Earnings and Dividends

View detailed summary of the earnings and dividend history of Marksans Pharma.

  • Marksans Pharma Ltd Earnings Results

    Marksans Pharma Ltd’s net profit fell -34.29% since last year same period to ₹58.32Cr in the Q1 2025-2026. On a quarterly growth basis, Marksans Pharma Ltd has generated -35.59% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Marksans Pharma Ltd Dividends May,2025

    In the quarter ending March 2025, Marksans Pharma Ltd has declared dividend of ₹0.80 per share on 19 May 2025 - translating a dividend yield of 0.78%.

    Read More about Dividends

Indices Featuring Marksans Pharma Stock

Check stock indices that include Marksans Pharma.

BSE Healthcare

₹45,130.04

0.87 (▲391.31%)

BSE Small-Cap

₹54,532.75

-0.01 (▲-4.28%)

Insights on Marksans Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, MARKSANS has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 29.37% to 30.75% in Jun 2025 quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 3.37% to 3.55% in Jun 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 10.7% return, outperforming this stock by 46.9%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 43.87% of holdings in Jun 2025 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 11.32% to 11.26% in Jun 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, MARKSANS stock has moved down by -28.4%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 723.8 Cr → 625.63 Cr (in ₹), with an average decrease of 13.6% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 104.56 Cr → 58.32 Cr (in ₹), with an average decrease of 24.5% per quarter

About Marksans Pharma Ltd

Marksans Pharma Limited is a public limited company that specializes in research, manufacture, marketing and sale of pharmaceutical formulations. Established in April 1982, the Company has its research and development centers located in Verna Goa and Navi Mumbai. On 30th March 2015, they issued and allotted 24006494 equity shares of ₹1 each to qualified institutional buyers for ₹54.67 per share under QIP. On 7th February 2015, the Company decided to redeem 1350000 cumulative redeemable preference shares of face value ₹100 each out of profits in tranches before due date of redemption, which was decided to be 27th March 2018. 50000 Bonds of USD 1000 value each were issued during the financial year 2015, out of which 49939 Bonds were bought and extinguished by the Company. 150000 preference shares of ₹100 each were redeemed at par in 2017 and the issued, subscribed and paidup preference share capital was reduced to 1100000 of ₹100 each. Marksans Pharma Limited is a long-standing public limited company offering research, manufacture, marketing and sale of pharmaceutical formulations.

Revenue: ₹619.99Cr as on June 2025 (Q1 FY26)
Net Profit: ₹58.20Cr as on June 2025 (Q1 FY26)
Listing date: 21 Jan, 2002
Chairperson Name: Mark Saldanha
OrganisationMarksans Pharma Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOMark Saldanha
E-voting on sharesClick here to vote

FAQs

What is Marksans Pharma share price today?

Marksans Pharma share price today stands at ₹178.37 as on at the close of the market. Marksans Pharma share today touched a day high of ₹181.6 and a low of ₹176.71.

What is the 52 week high and 52 week low range for Marksans Pharma share?

Marksans Pharma touched a 52 week high of ₹358.7 and a 52 week low of ₹165.52. Marksans Pharma share price today i.e. is closed at ₹178.37, which is -50.27% down from its 52 week high and 7.76% up from its 52 week low.

What is Marksans Pharma's market capitalisation today?

Marksans Pharma market capitalisation is ₹8,122.51 Cr as on .

How to buy Marksans Pharma shares?

To buy Marksans Pharma shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for MARKSANS or Marksans Pharma Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Marksans Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Marksans Pharma trading volume today?

Marksans Pharma trading volume is 8.77L as on . This means that 8.77L shares of Marksans Pharma were bought and sold on the stock market during today's trading session.